Font Size: a A A

Retrospective Comparison On Radical Hysterectomy After Neoadjuvant Chemotherapy Versus Concurrent Chemoradiation For Figo Stage ⅡB Cervical Cancer

Posted on:2019-12-27Degree:MasterType:Thesis
Country:ChinaCandidate:D ShiFull Text:PDF
GTID:2394330566482641Subject:Clinical medicine
Abstract/Summary:PDF Full Text Request
Objective:To compare outcome and long-term complications for FIGO stage IIB cervical cancer patients received radical hysterectomy after neoadjuvant chemotherapy combined with supplementary therapy versus concurrent chemoradiation.Methods : Retrospectively reviewed the medical records of FIGO stage IIB cervical carcinoma patients from February 2011 to April 2014 in First affiliated hospital of Chongqing Medical University.A total of the data of 121 patients underwent radical hysterectomy after neoadjuvant chemotherapy combined with supplementary therapy(NACT+RH group),There were 85 patients received concurrent chemoradiation(CCRT group).Long-term complications(Radioactive enteritis,Radioactive cystitis,Lower limb lymph-Edema)、progression-free survivals(PFS)and overall survivals(OS)were compared between the two groups.Results:There were less long-term complications in NACT+RH thanthose in CCRT group(P=0.002).Five year PFS were similar in both groups(84.87% vs 84.71% respectively),and there was no statistically significant difference in disease-free survival curve(Log-rank,P = 0.701).Five-year OS 89.10% vs 84.94% were observed for the NACT+RH group and CCRT group,and there was also no statistically significant difference between the two groups(Log-rank,P=0.565).Conclusion:Disease-free survival(PFS)and overall survival(OS)of NACT+RH group has not been improved significantly compared to CCRT group.Radioactive cystitis and enteritis of the former is less than the latter,but the incidence of lower limb edema is higher than the latter.
Keywords/Search Tags:Neoadjuvant chemotherapy, Concurrent chemoradiation, Cervical cancer
PDF Full Text Request
Related items
The Efficacy And Safety Of Neoadjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy In The Treatment Of Locally Advanced Cervical Cancer-a Meta Analysis
Comparative Clinical Research Of The Short-term Efficacy And Security Of Preoperative Brachytherapy Combinded Concurrent Chemotherapy And Neoadjuvant Chemotherapy For Patients With FIGO Stage â… B2 And â…¡A2 Cervical Cancer
Comparison Of The ⅡB And ⅢB Cervical Squamous Cell Carcinoma Efficacy And Prognosis Of Concurrent Chemoradiotherapy Concurrent Chemoradiotherapy After Neoadjuvant Chemotherapy
Role Of Adjuvant Chemotherapy After Concurrent Chemoradiation For Locally Advanced Cervical Cancer
The Clinical Study Of Taxane And Nedaplatin Neoadjuvant Chemotherapy Followed By Concurrent Chemoradiation For Locoregionally Advanced Nasopharyngeal Carcinoma
Study Of Short-term Efficacy And Safety Of Lobaplatin Combined With Paclitaxel Neoadjuvant Chemotherapy Followed By Concurrent Chemoradiotherapy For Stage ⅡB-ⅢB Cervical Squamous Cell Cancer
Efficacy Of Concurrent Chemoradiation Followed By Surgery Versus Concurrent Chemoradiation For The Treatment Of Locally Advanced Cervical Cancer: A Meta-analysis
Neoadjuvant Chemotherapy Followed By Surgery Versus Concurrent Chemotherapy In Patients With Locally Advanced Cervical Cancer: A Clinical Controlled Trial
Comparison Of The Results Of Neoadjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy And Concurrent Chemoradiotherapy In Advanced Cervical Cancer
10 Neoadjuvant Chemotherapy Followed By Radical Surgery Versus Chemotherapy Followed By Chemoradiotherapy In Patients With Stage ⅡA-ⅢA Cervical Carcinoma